Medicare Updated Articles Display Page

JF LOB Updated Artcles
Article ID Modified By Modified On Title
30205411 James Marko 2026-06-25 13:30:16.927 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R18 - Effective June 25, 2026
30205147 James Marko 2026-06-25 12:27:27.599 Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence (A53359) - R14 - Effective April 6, 2026
30097295 James Marko 2026-06-22 17:24:57.225 Reason Code 37256 Assigning in Error
30205480 James Marko 2026-06-25 13:34:50.04 MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 10, 2026
30205548 James Marko 2026-06-25 13:39:19.729 Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) - R7 - Effective June 25, 2026
30205428 James Marko 2026-06-25 13:30:23.058 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R18 - Effective June 25, 2026
30097330 James Marko 2026-06-23 17:17:49.488 Sequestration Calculation Error
30205198 James Marko 2026-06-25 12:34:36.532 Billing and Coding: IUD (Hormone-Eluting) for Endometrial Hyperplasia - CPT 58999 (A55061) - R6 - Effective July 1, 2026
30202916 James Marko 2026-06-23 16:11:43.767 Reminder: Proper Use of JW and JZ Modifiers for Drug Billing
30205130 James Marko 2026-06-25 12:27:22.579 Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence (A53359) - R14 - Effective April 6, 2026
30193602 James Marko 2026-06-19 16:09:23.988 Reminder: Proper Use of JW and JZ Modifiers for Drug Billing
30205215 James Marko 2026-06-25 12:34:42.916 Billing and Coding: IUD (Hormone-Eluting) for Endometrial Hyperplasia - CPT 58999 (A55061) - R6 - Effective July 1, 2026
30205497 James Marko 2026-06-25 13:34:56.236 MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 10, 2026
30205572 James Marko 2026-06-25 13:39:25.237 Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) - R7 - Effective June 25, 2026
JD LOB Updated Artcles
Article ID Modified By Modified On Title
30205034 James Marko 2026-06-25 12:19:13.677 LCD and Policy Article Revisions Summary for June 25, 2026
JE LOB Updated Artcles
Article ID Modified By Modified On Title
30205514 James Marko 2026-06-25 13:39:08.765 Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) - R7 - Effective June 25, 2026
30097342 James Marko 2026-06-23 17:17:44.527 Sequestration Calculation Error
30205394 James Marko 2026-06-25 13:30:11.352 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R18 - Effective June 25, 2026
30205164 James Marko 2026-06-25 12:34:23.857 Billing and Coding: IUD (Hormone-Eluting) for Endometrial Hyperplasia - CPT 58999 (A55061) - R6 - Effective July 1, 2026
30205113 James Marko 2026-06-25 12:27:17.367 Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence (A53359) - R14 - Effective April 6, 2026
30205446 James Marko 2026-06-25 13:34:36.717 MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 10, 2026
30205531 James Marko 2026-06-25 13:39:14.021 Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) - R7 - Effective June 25, 2026
30205181 James Marko 2026-06-25 12:34:30.475 Billing and Coding: IUD (Hormone-Eluting) for Endometrial Hyperplasia - CPT 58999 (A55061) - R6 - Effective July 1, 2026
30205377 James Marko 2026-06-25 13:30:04.917 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R18 - Effective June 25, 2026
30193619 James Marko 2026-06-19 16:09:22.354 Reminder: Proper Use of JW and JZ Modifiers for Drug Billing
30097307 James Marko 2026-06-22 17:25:47.741 Reason Code 37256 Assigning in Error
30202933 James Marko 2026-06-23 16:11:48.339 Reminder: Proper Use of JW and JZ Modifiers for Drug Billing
30204187 James Marko 2026-06-24 19:01:28.213 California Exclusive: IRF Review Choice Demonstration - Cycle One Trends and Observations Webinar - 07/30/2026
30205463 James Marko 2026-06-25 13:34:43.006 MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 10, 2026
30205096 James Marko 2026-06-25 12:27:12.084 Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence (A53359) - R14 - Effective April 6, 2026
JA LOB Updated Artcles
Article ID Modified By Modified On Title
30205053 James Marko 2026-06-25 12:19:19.591 LCD and Policy Article Revisions Summary for June 25, 2026